Medtronic Cardiovascular Surgery-the Heart Valve Division recalls Medtronic EnVeo R Delivery Catheter System (DCS), Models: ENVEOR-L, ENVEOR-L-C, and ENVEOR-US. Designed to replace the…
- Recall date
- August 3, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-2546-2016
- FDA classification
- Class II
- Brand / firm
- Medtronic Cardiovascular Surgery-the Heart Valve Division
- Sold / distributed
- Worldwide Distribution -- US, Australia, Austria, Belgium, Brazil, Colombia, Costa Rica, Czech Republic, Denmark, Dominican Republic, Egypt, Estonia, Finland, France, Germany, Greece, Hong Kong, Hungary, Iceland, India, Iran, Ireland, Israel, Italy, Kazakhstan, Korea, Kuwait, Latvia, Lebanon, Lithu…
Why it was recalled
Potential for vascular trauma with the use of the Medtronic EnVeo R Delivery Catheter System (DCS).
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Medtronic EnVeo R Delivery Catheter System (DCS), Models: ENVEOR-L, ENVEOR-L-C, and ENVEOR-US. Designed to replace the native or surgical bioprosthetic aortic heart valve without open heart surgery and without concomitant surgical removal of the failed valve.
Get recall alerts
Free email alert whenever Medtronic Cardiovascular Surgery-the Heart Valve Division has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Medtronic Cardiovascular Surgery-the Heart Valve Division